**Abstract**

**Background:** There is a compeling evidence that alcohol induced neurotoxicity were related to glutamate excitotoxicity. It is hypothesized that the low affinity NMDA receptor antagonist, memantine would improve cognitive function of patient with alcoholic dementia. The aim of this study was to testify this hypothesis and to evaluate its effect of cognitive improvement of patient with alcoholic dementia.

**Method:** The study is planned as a 12-week, open-label study of 20mg memantine, a NMDA antagonist, as treatment for cognitive and neurobiological problem in patients with alcoholic dementia. CERAD-K and K-MMSE was administered to total 27 male patients diagnosed as alcoholic dementia according to the DSM-IV criteria before and after 12-week memantine medication.

**Results:** Word list recall, word list recognition, time orientation, drawing a interlocking pentagon, and K-MMSE total score of the patients were improved significantly after the memantine trial.

**Conclusions:** Memantine has significant effects on the cognitive function improvement of the patients with alcoholic dementia. Limitation and future direction of this study were discussed.
